Drug news
I-Stent (Glaukos Corporation) is FDA approved for Cataract Surgery
The iStent Trabecular Micro-Bypass Stent System, Model GTS100R/L, from Glaukos Corporation, was approved by the FDA on 26 June 2012. This is the first device approved for use in combination with cataract surgery to reduce pressure inside the eye (intraocular pressure) in adult patients with mild or moderate open-angle glaucoma and a cataract who are currently being treated with medication to reduce intraocular pressure.The iStent is a small titanium tube placed through the meshwork of tissue. This creates an opening between the eye�s anterior chamber and Schlemm�s canal that allows fluid to drain, potentially decreasing intraocular pressure.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins